Leading the way with COVID-19 autoimmunity
Researching autoimmunity in COVID-19 has been a lonely and frustrating world. Consistently going against the tide of scientific thinking drains your enthusiasm. This is however the reality of making a new path.
Over the past few weeks, the evidence is accumulating about autoimmune responses in COVID-19. Additionally, the largest study done on plasma ACE2 levels demonstrate that elevation is directly related to cardiometabolic mortality.
Putting that data together strongly suggests that autoimmune phenomena in severe COVID-19 are likely to be caused by an elevated plasma ACE2 combining with viral spike protein.
Part of my role is to highlight this thinking to as many individuals who could help shift our direction. Especially important as the leader of the free world has also been affected.
The destination is in sight, just need to keep pushing forward.